Hagino, Takeshi
Ikegame, Kazuhiro https://orcid.org/0000-0002-5421-7470
Tanaka, Hidenori
Kanda, Yoshinobu
Kaida, Katsuji
Fukuda, Takahiro
Kondo, Yukio
Sato, Maho
Doki, Noriko
Nakamae, Hirohisa
Matsuoka, Ken-ichi
Mori, Yasuo
Sano, Hideki
Eto, Tetsuya
Kawakita, Toshiro
Hashii, Yoshiko
Ichinohe, Tatsuo
Atsuta, Yoshiko
Kanda, Junya
,
Article History
Received: 17 July 2024
Revised: 13 February 2025
Accepted: 13 February 2025
First Online: 20 March 2025
Declarations
:
: Hirohisa Nakamae received research funding from Astellas Pharma Inc. and Novartis Pharma K.K., and honoraria from Astellas Pharma Inc., Kyowa Kirin Co., Ltd., NIPPON SHINYAKU Co., Ltd., and Novartis Pharma K.K. The authors declare no competing financial interests. One of the authors, Yoshinobu Kanda, is the editor of the International Journal of Hematology.